Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain.

MLA

Sadeq, Alyaa, et al. “Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain.” Clinical Nuclear Medicine, vol. 47, no. 7, July 2022, pp. 627–28. EBSCOhost, https://doi.org/10.1097/RLU.0000000000004162.

APA

Sadeq, A., Usmani, S., Esmail, A. A., Fathallah, W., Alfeeli, M. A., & Marafi, F. (2022). Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain. Clinical Nuclear Medicine, 47(7), 627–628. https://doi.org/10.1097/RLU.0000000000004162

Chicago

Sadeq, Alyaa, Sharjeel Usmani, Abdulredha A Esmail, Wael Fathallah, Mahmoud A Alfeeli, and Fahad Marafi. 2022. “Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain.” Clinical Nuclear Medicine 47 (7): 627–28. doi:10.1097/RLU.0000000000004162.